Amneal to Present at Upcoming Investor Conferences

August 31, 2018

BRIDGEWATER, N.J., Aug. 31, 2018 /PRNewswire/ -- Amneal Pharmaceuticals, Inc.(NYSE: AMRX) today announced that it plans to participate at the following upcoming investor conferences.

  • Wells Fargo 2018 Healthcare Conference at 9:10 a.m. ET on September 6, 2018 in Boston, MA.
  • Morgan Stanley 16th Annual Global Healthcare Conference at 11:05 a.m. ET on September 12, 2018 in New York, NY.

(PRNewsfoto/Amneal Pharmaceuticals, Inc.)

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at The archived presentations will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has approximately 6,500 employees in its operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.

Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company markets a portfolio of branded pharmaceutical products through its Impax Specialty Pharma division focused principally on central nervous system disorders and parasitic infections. For more information, visit

Mark Donohue
Investor Relations and Corporate Communications      
(215) 558-4526                                                                                                           

Cision View original content with multimedia:

SOURCE Amneal Pharmaceuticals, Inc.